Raras
Buscar doenças, sintomas, genes...
Agamaglobulinemia sindromática
ORPHA:229720DOENÇA RARA

Uma deficiência de anticorpos que faz parte de uma síndrome mais abrangente.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma deficiência de anticorpos que faz parte de uma síndrome mais abrangente.

Publicações científicas
19.949 artigos
Último publicado: 2026
Medicamentos
3 registrados
LENIOLISIB, LENIOLISIB PHOSPHATE, APILIMOD

Tem tratamento?

3 medicamentos registrados
Ver detalhes, fases e interações →
LENIOLISIBLENIOLISIB PHOSPHATEAPILIMOD
🏥
SUS: Cobertura mínimaScore: 5%
Triagem neonatal (Fase 4)
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫁
Pulmão
16 sintomas
📏
Crescimento
15 sintomas
🩸
Sangue
14 sintomas
🦴
Ossos e articulações
11 sintomas
🫃
Digestivo
11 sintomas
🫘
Rins
9 sintomas

+ 71 sintomas em outras categorias

Características mais comuns

Hipoglicemia
Diferenciação defeituosa de linfócitos B
Insuficiência adrenal deficiente em adrenocorticotrofina
Nível diminuído de IgG circulante
Positividade do anticorpo antinuclear
Nível reduzido de iso-hemaglutinina
188sintomas
Sem dados (188)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 188 características clínicas mais associadas, ordenadas por frequência.

HipoglicemiaHypoglycemia
Diferenciação defeituosa de linfócitos BDefective B cell differentiation
Insuficiência adrenal deficiente em adrenocorticotrofinaAdrenocorticotropin deficient adrenal insufficiency
Nível diminuído de IgG circulanteDecreased circulating IgG level
Positividade do anticorpo antinuclearAntinuclear antibody positivity

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa4
Total histórico19.949PubMed
Últimos 10 anos200publicações
Pico202353 papers
Linha do tempo
2022Hoje · 2026📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: KREC (Kappa-deleting Recombination Excision Circles)
Fase 4 do PNTNpending
Incidência no Brasil: 1:200.000

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

14 genes identificados com associação a esta condição.

IRF2BP2Interferon regulatory factor 2-binding protein 2Disease-causing germline mutation(s) inModerado
FUNÇÃO

Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities (PubMed:12799427). Represses the NFAT1-dependent transactivation of NFAT-responsive promoters (PubMed:21576369). Acts as a coactivator of VEGFA expression in cardiac and skeletal muscles (PubMed:20702774). Plays a role in immature B-cell differentiation (PubMed:27016798)

LOCALIZAÇÃO

CytoplasmNucleus

MECANISMO DE DOENÇA

Immunodeficiency, common variable, 14

A primary immunodeficiency resulting in recurrent sinopulmonary infections since early childhood, and characterized by hypogammaglobulinemia with undetectable IgG and IgA, poor response to vaccination, and decreased levels of switched memory B cells. CVID14 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
137.0 TPM
Aorta
113.8 TPM
Ovário
113.3 TPM
Skin Not Sun Exposed Suprapubic
103.1 TPM
Skin Sun Exposed Lower leg
101.0 TPM
OUTRAS DOENÇAS (2)
immunodeficiency, common variable, 14acute promyelocytic leukemia
HGNC:21729UniProt:Q7Z5L9
NFKB2Nuclear factor NF-kappa-B p100 subunitDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (7)
TAK1-dependent IKK and NF-kappa-B activation TRAF6 mediated NF-kB activationRIP-mediated NFkB activation via ZBP1DEx/H-box helicases activate type I IFN and inflammatory cytokines production IkBA variant leads to EDA-ID
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
181.3 TPM
Baço
75.9 TPM
Pulmão
63.1 TPM
Cólon sigmoide
61.8 TPM
Fallopian Tube
53.4 TPM
OUTRAS DOENÇAS (2)
immunodeficiency, common variable, 10deficiency in anterior pituitary function - variable immunodeficiency syndrome
HGNC:7795UniProt:Q00653
TNFRSF13CTumor necrosis factor receptor superfamily member 13CDisease-causing germline mutation(s) inTolerante
FUNÇÃO

B-cell receptor specific for TNFSF13B/TALL1/BAFF/BLyS. Promotes the survival of mature B-cells and the B-cell response

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (2)
TNFR2 non-canonical NF-kB pathwayTNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 4

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
128.3 TPM
Baço
91.7 TPM
Intestino delgado
21.3 TPM
Sangue
7.4 TPM
Skin Sun Exposed Lower leg
4.5 TPM
OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 4
HGNC:17755UniProt:Q96RJ3
LRBALipopolysaccharide-responsive and beige-like anchor proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in coupling signal transduction and vesicle trafficking to enable polarized secretion and/or membrane deposition of immune effector molecules (By similarity). Involved in phagophore growth during mitophagy by regulating ATG9A trafficking to mitochondria (PubMed:33773106)

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneGolgi apparatus, trans-Golgi network membraneLysosome membrane

MECANISMO DE DOENÇA

Immunodeficiency, common variable, 8, with autoimmunity

An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early-childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
36.2 TPM
Skin Sun Exposed Lower leg
19.1 TPM
Pituitária
18.1 TPM
Skin Not Sun Exposed Suprapubic
18.1 TPM
Esôfago - Mucosa
16.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
combined immunodeficiency due to LRBA deficiency
HGNC:1742UniProt:P50851
CD81CD81 antigenDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (TERMs), which act as platforms for receptor clustering and signaling. Essential for trafficking and compartmentalization of CD19 receptor on the surface of activated B cells (PubMed:16449649, PubMed:20237408, PubMed:27881302). Upon initial encounter with microbial pathogens, enables the assembly of CD19-CR2/CD21 and B cell receptor (BCR) complexes at signaling TERMs, lowering the threshold dose

LOCALIZAÇÃO

Cell membraneBasolateral cell membrane

VIAS BIOLÓGICAS (2)
Regulation of Complement cascadeImmunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 6

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 6
HGNC:1701UniProt:P60033
IL21Interleukin-21Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Cytokine with immunoregulatory activity. May promote the transition between innate and adaptive immunity. Induces the production of IgG(1) and IgG(3) in B-cells (By similarity). Implicated in the generation and maintenance of T follicular helper (Tfh) cells and the formation of germinal-centers. Together with IL6, control the early generation of Tfh cells and are critical for an effective antibody response to acute viral infection (By similarity). May play a role in proliferation and maturation

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Interleukin-21 signaling
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 11

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.4 TPM
OUTRAS DOENÇAS (1)
IL21-related infantile inflammatory bowel disease
HGNC:6005UniProt:Q9HBE4
CR2Complement receptor type 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Serves as a receptor for various ligands including complement component CD3d, HNRNPU OR IFNA1 (PubMed:1849076, PubMed:21527715, PubMed:7753047). When C3d is bound to antigens, attaches to C3d on B-cell surface and thereby facilitates the recognition and uptake of antigens by B-cells (PubMed:21527715). This interaction enhances B-cell activation and subsequent immune responses. Forms a complex with several partners on the surface of B-cells including CD19, FCRL5 and CD81, to form the B-cell corec

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Regulation of Complement cascade
MECANISMO DE DOENÇA

Systemic lupus erythematosus 9

A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

OUTRAS DOENÇAS (3)
immunodeficiency, common variable, 7systemic lupus erythematosussystemic lupus erythematosus, susceptibility to, 9
HGNC:2336UniProt:P20023
IKZF1DNA-binding protein IkarosDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription regulator of hematopoietic cell differentiation (PubMed:17934067). Binds gamma-satellite DNA (PubMed:17135265, PubMed:19141594). Plays a role in the development of lymphocytes, B- and T-cells. Binds and activates the enhancer (delta-A element) of the CD3-delta gene. Repressor of the TDT (fikzfterminal deoxynucleotidyltransferase) gene during thymocyte differentiation. Regulates transcription through association with both HDAC-dependent and HDAC-independent complexes. Targets the 2

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
NOTCH3 Intracellular Domain Regulates Transcription
EXPRESSÃO TECIDUAL(Ubíquo)
Baço
34.6 TPM
Sangue
30.1 TPM
Linfócitos
21.4 TPM
Intestino delgado
11.1 TPM
Pulmão
10.5 TPM
OUTRAS DOENÇAS (3)
pancytopenia due to IKZF1 mutationsStevens-Johnson syndromeB-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
HGNC:13176UniProt:Q13422
CD19B-lymphocyte antigen CD19Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions as a coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes (PubMed:29523808). Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens (PubMed:1373518, PubMed:16672701, PubMed:2463100). Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores (PubMed:12387743, PubMed:16672701, PubMed:9317126, PubMed:9382888). Is not requ

LOCALIZAÇÃO

Cell membraneMembrane raft

VIAS BIOLÓGICAS (3)
Antigen activates B Cell Receptor (BCR) leading to generation of second messengersRegulation of Complement cascadeImmunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 3

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 3
HGNC:1633UniProt:P15391
ICOSInducible T-cell costimulatorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Stimulatory receptor expressed in activated or antigen-experienced T-cells that plays an important role in the immune response (PubMed:9930702). Upon binding to its ligand ICOSL expressed on antigen presenting cells (APCs), delivers costimulatory signals that enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines including IL10, up-regulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B-cells (Pu

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (1)
Nuclear events stimulated by ALK signaling in cancer
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 1

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

EXPRESSÃO TECIDUAL(Baixa expressão)
Baço
3.4 TPM
Pulmão
2.2 TPM
Intestino delgado
2.1 TPM
Sangue
2.0 TPM
Adipose Visceral Omentum
0.6 TPM
OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 1
HGNC:5351UniProt:Q9Y6W8
TNFRSF13BTumor necrosis factor receptor superfamily member 13BDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T-cell function and the regulation of humoral immunity

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (1)
TNFs bind their physiological receptors
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 2

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
214.4 TPM
Baço
29.6 TPM
Intestino delgado
7.7 TPM
Sangue
1.5 TPM
Cólon transverso
1.4 TPM
OUTRAS DOENÇAS (2)
immunoglobulin A deficiency 2immunodeficiency, common variable, 2
HGNC:18153UniProt:O14836
NFKB1Nuclear factor NF-kappa-B p105 subunitDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p5

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
TAK1-dependent IKK and NF-kappa-B activation TRAF6 mediated NF-kB activationRIP-mediated NFkB activation via ZBP1DEx/H-box helicases activate type I IFN and inflammatory cytokines production IkBA variant leads to EDA-ID
MECANISMO DE DOENÇA

Immunodeficiency, common variable, 12, with autoimmunity

A primary immunodeficiency characterized by hypogammaglobulinemia and recurrent bacterial infections. About half of patients develop autoimmune features, including cytopenia, as well as generalized inflammation and lymphoproliferation manifest as lymphadenopathy or hepatosplenomegaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
98.0 TPM
Cervix Ectocervix
35.2 TPM
Pulmão
33.6 TPM
Cervix Endocervix
33.4 TPM
Útero
33.2 TPM
OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 12
HGNC:7794UniProt:P19838
MS4A1B-lymphocyte antigen CD20Disease-causing germline mutation(s) inTolerante
FUNÇÃO

B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes (PubMed:12920111, PubMed:3925015, PubMed:7684739). Functions as a store-operated calcium (SOC) channel component promoting calcium influx after activation by the B-cell receptor/BCR (PubMed:12920111, PubMed:18474602, PubMed:7684739)

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Immunodeficiency, common variable, 5

A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
556.7 TPM
Baço
267.8 TPM
Intestino delgado
46.0 TPM
Sangue
10.7 TPM
Pulmão
3.5 TPM
OUTRAS DOENÇAS (1)
immunodeficiency, common variable, 5
HGNC:HGNC:7315UniProt:P11836
SEC61A1Protein transport protein Sec61 subunit alpha isoform 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of SEC61 channel-forming translocon complex that mediates transport of signal peptide-containing precursor polypeptides across the endoplasmic reticulum (ER) (PubMed:12475939, PubMed:22375059, PubMed:28782633, PubMed:29719251, PubMed:32814900). Forms a ribosome receptor and a gated pore in the ER membrane, both functions required for cotranslational translocation of nascent polypeptides (PubMed:22375059, PubMed:28782633, PubMed:29719251). May cooperate with auxiliary protein SEC62, SEC

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
SRP-dependent cotranslational protein targeting to membrane
MECANISMO DE DOENÇA

Tubulointerstitial kidney disease, autosomal dominant 5

A form of autosomal dominant tubulointerstitial kidney disease, a genetically heterogeneous disorder characterized by slowly progressive loss of kidney function, bland urinary sediment, hyperuricemia, absent or mildly increased albuminuria, lack of severe hypertension during the early stages, and normal or small kidneys on ultrasound. Renal histology shows variable abnormalities including interstitial fibrosis with tubular atrophy, microcystic dilatation of the tubules, thickening of tubular basement membranes, medullary cysts, and secondary glomerulosclerotic or glomerulocystic changes with abnormal glomerular tufting. There is significant variability, as well as incomplete penetrance.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
395.9 TPM
Pituitária
215.7 TPM
Cervix Endocervix
198.3 TPM
Pâncreas
192.4 TPM
Pulmão
180.5 TPM
OUTRAS DOENÇAS (3)
hyperuricemic nephropathy, familial juvenile type 4immunodeficiency, common variable, 15neutropenia, severe congenital, 11, autosomal dominant
HGNC:18276UniProt:P61619

Medicamentos e terapias

LENIOLISIBPhase 2

Mecanismo: PI3-kinase p110-delta subunit inhibitor

LENIOLISIB PHOSPHATEPhase 2

Mecanismo: PI3-kinase p110-delta subunit inhibitor

APILIMODPhase 1

Mecanismo: 1-phosphatidylinositol 3-phosphate 5-kinase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

175 variantes patogênicas registradas no ClinVar.

🧬 IRF2BP2: NM_182972.3(IRF2BP2):c.1617_1624dup (p.Gly542fs) ()
🧬 IRF2BP2: GRCh37/hg19 1q21.1-44(chr1:143932350-249224684)x3 ()
🧬 IRF2BP2: NM_182972.3(IRF2BP2):c.1191del (p.Phe397fs) ()
🧬 IRF2BP2: NM_182972.3(IRF2BP2):c.763G>A (p.Ala255Thr) ()
🧬 IRF2BP2: NM_182972.3(IRF2BP2):c.1615A>G (p.Lys539Glu) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

46 vias biológicas associadas aos genes desta condição.

RIP-mediated NFkB activation via ZBP1 DEx/H-box helicases activate type I IFN and inflammatory cytokines production PKMTs methylate histone lysines TAK1-dependent IKK and NF-kappa-B activation Interleukin-1 processing SUMOylation of immune response proteins IkBA variant leads to EDA-ID Dectin-1 mediated noncanonical NF-kB signaling NIK-->noncanonical NF-kB signaling The NLRP3 inflammasome TRAF6 mediated NF-kB activation Purinergic signaling in leishmaniasis infection Regulation of PD-L1(CD274) transcription TNFR2 non-canonical NF-kB pathway TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell Regulation of Complement cascade Interleukin-21 signaling NOTCH3 Intracellular Domain Regulates Transcription PIP3 activates AKT signaling Constitutive Signaling by Aberrant PI3K in Cancer PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Antigen activates B Cell Receptor (BCR) leading to generation of second messengers Nuclear events stimulated by ALK signaling in cancer Co-stimulation by ICOS TNFs bind their physiological receptors Activation of NF-kappaB in B cells Regulated proteolysis of p75NTR Downstream TCR signaling NF-kB is activated and signals survival Senescence-Associated Secretory Phenotype (SASP) FCERI mediated NF-kB activation Transcriptional regulation of white adipocyte differentiation CLEC7A (Dectin-1) signaling CD209 (DC-SIGN) signaling CLEC7A/inflammasome pathway MAP3K8 (TPL2)-dependent MAPK1/3 activation Neutrophil degranulation Transcriptional Regulation by VENTX Interleukin-1 signaling HCMV Early Events SARS-CoV-1 activates/modulates innate immune responses Regulation of NFE2L2 gene expression Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells ER-Phagosome pathway SRP-dependent cotranslational protein targeting to membrane

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 22
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 3 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Agamaglobulinemia sindromática

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Rituximab-induced hypogammaglobulinemia in childhood nephrotic syndrome: a systematic review and meta-analysis.

European journal of pediatrics2026 Mar 17

Este estudo revelou que o rituximab, um tratamento frequentemente usado para a síndrome nefrótica pediátrica complicada, causa hipogamaglobulinemia em 11.4% das crianças. Essa condição aumenta significativamente o risco de infecções graves, incluindo quatro casos fatais entre os episódios de hipogamaglobulinemia observados. É crucial que médicos e famílias ponderem cuidadosamente os riscos potenciais de infecção contra os benefícios do rituximab no manejo da doença.

🇧🇷 traduzido
#2

A patient with WHIM syndrome presenting relatively low TREC, KREC, and housekeeping gene levels by newborn screening -a case report and the literature review.

Immunological medicine2026 Mar 07

A Síndrome de WHIM é uma doença imunológica genética que causa infecções recorrentes e hipogamaglobulinemia, sendo desafiadora de diagnosticar por não apresentar todas as suas manifestações em todos os pacientes. Este artigo destaca que testes de triagem neonatal (TREC e KREC), usados para outras imunodeficiências, podem mostrar níveis relativamente baixos na Síndrome de WHIM. É crucial que médicos e pacientes saibam que mesmo resultados *acima* do limiar de corte padrão para outras doenças podem indicar a síndrome, exigindo investigação adicional para um diagnóstico e tratamento precoce.

🇧🇷 traduzido
#3

Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity.

Expert review of clinical immunology2026 Feb

O transplante de células-tronco hematopoiéticas (TCTH) é uma terapia curativa em expansão para um número crescente de erros inatos de imunidade (IEI). Este artigo ressalta que o TCTH, antes restrito a algumas condições, está sendo agora explorado com sucesso para IEIs recém-descritas ou onde seu uso era limitado, como a **amaglobulinemia ligada ao X**. Para pacientes e médicos, é crucial saber que, embora a decisão para estas novas indicações seja complexa, intervenções mais precoces em pacientes mais jovens e com menos comorbidades estão associadas a melhores resultados.

🇧🇷 traduzido
#4

First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia.

Frontiers in immunology2026

Um programa de triagem neonatal em larga escala na Rússia, utilizando marcadores TREC e KREC, revelou-se crucial para a identificação precoce de diversas imunodeficiências graves, incluindo formas sindrômicas de agamaglobulinemia. Essa triagem permite o diagnóstico precoce, possibilitando o início oportuno de tratamentos específicos, como terapia de reposição de imunoglobulinas ou transplante de células-tronco. Para pacientes e médicos, essa intervenção precoce é vital para reduzir o risco de infecções graves, melhorar os resultados neurodesenvolvimentais e prevenir danos irreversíveis.

🇧🇷 traduzido
#5

Good's Syndrome Mirrors a Combined Immunodeficiency with Anti-Cytokine Antibodies in the Total Absence of B Cells.

Journal of clinical immunology2026 Feb 17

A Síndrome de Good (SG) é uma imunodeficiência em adultos caracterizada pela ausência completa de células B, mesmo nos tecidos linfoides, e pela presença de anticorpos contra citocinas (como os anti-interferons), que persistem por anos. Este estudo sugere que a SG é uma imunodeficiência combinada, diferente de outras agamaglobulinemias, e que a sua causa provável é um problema na tolerância imunológica associado ao timoma, e não a uma falha genética única.

🇧🇷 traduzido

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Rituximab-induced hypogammaglobulinemia in childhood nephrotic syndrome: a systematic review and meta-analysis.

European journal of pediatrics
2026

A patient with WHIM syndrome presenting relatively low TREC, KREC, and housekeeping gene levels by newborn screening -a case report and the literature review.

Immunological medicine
2026

Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity.

Expert review of clinical immunology
2026

First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia.

Frontiers in immunology
2026

Good's Syndrome Mirrors a Combined Immunodeficiency with Anti-Cytokine Antibodies in the Total Absence of B Cells.

Journal of clinical immunology
2026

Translational immunothrombosis in autoimmune Heparin-Induced thrombocytopenia: targeting the FcγRIIa-Syk-BTK and complement pathways.

Clinical and experimental medicine
2026

Immuno-deficient features of thymoma-associated myasthenia gravis patients with hypogammaglobulinemia: A condition comparable to Good's syndrome.

Journal of neuroimmunology
2026

COVID-19 Outcomes and Risk Factors for Hospitalization in Adult Patients With Primary Immunodeficiency.

Allergy, asthma & immunology research
2026

Immunoglobulin disorders in pediatric chronic rhinosinusitis.

Current opinion in allergy and clinical immunology
2025

A pharmacovigilance study of Bruton's tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.

Frontiers in immunology
2025

Good's Syndrome-A Rare Cause of Acquired Adult Immunodeficiency: A Case Report.

The Journal of the Association of Physicians of India
2025

Case Report: A simple case of drug-induced secondary antibody deficiency or a rare primary immune deficiency?

Frontiers in immunology
2025

Sclerosing Cholangitis and Multiple Liver Abscesses in a Patient with Thymoma, Myasthenia Gravis, and Immune Deficiency (Good's Syndrome).

The American journal of case reports
2025

Sustained remission with PD-1 and BTK inhibitors maintenance after chimeric antigen receptor T-cell therapy in CNS lymphoma.

Cancer immunology, immunotherapy : CII
2026

Five Years of Combined Newborn Screening Quantifying TREC and KREC in Switzerland.

The journal of allergy and clinical immunology. In practice
2025

BTK Inhibitor Synergizes With CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients With Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic Clinical Trial.

Cancer medicine
2025

Novel SYK Variant Causes Enhanced SYK Autophosphorylation and PI3K Activation in an Antibody-Deficient Patient.

Journal of clinical immunology
2025

Early-onset neutropenia and mixed phenotype in ADA2 deficiency: diagnostic and therapeutic challenges.

Frontiers in immunology
2025

[Primary immunodeficiency with hypogammaglobulinemia and minimum midline defect].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2025

[Ormond syndrome: a rare diagnosis in a patient with hypogammaglobulinemia secondary to rituximab].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2025

Thrombocytopenia in patients with inborn errors of immunity.

BMC immunology
2025

The prevalence of allergic manifestations in inborn errors of immunity: a retrospective cohort study.

BMC immunology
2025

Early-onset vasculitis: a toddler with ADA2 deficiency.

BMJ case reports
2025

Membranous nephropathy preceding Bing-Neel syndrome: successful treatment with tirabrutinib.

Journal of nephrology
2025

Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?

Allergy and asthma proceedings
2025

Case Report: A novel CXCR4 variant (p.S341Y) in a family with a pathogenic NFKB1 variant and variable clinical manifestations.

Frontiers in immunology
2025

Interstitial lung disease associated with immunodeficiency with hypogammaglobulinemia: Five case reports.

Respiratory investigation
2025

Pediatric and Adult Inborn Errors of Immunity and COVID-19: A Comparative Study.

Journal of medical virology
2025

Impairment of Collagen-Induced Thrombus Formation in Microfluidic Assay Correlates with Bleeding Complications Better Than Cytofluorometric Parameters.

Thrombosis and haemostasis
2025

Double Trouble: A Case of ARDS as a Consequence of Influenza and Plasma Donation Causing Severe Neutropenia and Hypogammaglobulinemia.

Journal of investigative medicine high impact case reports
2025

Shashi-Pena syndrome with late-onset specific hypogammaglobinaemia and autoimmune cytopenia.

BMJ case reports
2025

FNIP1 Deficiency: Pathophysiology and Clinical Manifestations of a Rare Syndromic Primary Immunodeficiency.

Current issues in molecular biology
2025

Functional rescue of a fatal ERAD mutation via alternative splicing.

bioRxiv : the preprint server for biology
2025

Paracentral acute middle maculopathy as a major clinical manifestation of adenosine deaminase-2 deficiency.

BMC ophthalmology
2025

Adenosine and Adenosine Deaminase Contrary Manifestations in Immunity.

Scandinavian journal of immunology
2025

Uncovering the mechanism of Buyang Huanwu Decoction in regulating mitochondrial dysfunction to alleviate atherosclerosis: BTK, PREPL, and P2RX7 proteins play key roles.

International journal of biological macromolecules
2025

Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's Macroglobulinemia.

Seminars in hematology
2025

Clinicopathologic Features and the Spectrum of Myelokathexis in Warts, Hypogammaglobulinemia, Infections, Myelokathexis Syndrome.

Laboratory investigation; a journal of technical methods and pathology
2025

Heterozygous deletion of 10q24.31-q24.33- a new syndrome associated with multiple congenital anomalies: case report and literature review.

Neurological research and practice
2025

Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls.

Frontiers in immunology
2025

Gene therapy for inborn errors of immunity: Current clinical progress.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
2025

Remibrutinib in Chronic Spontaneous Urticaria.

The New England journal of medicine
2025

Bruton's tyrosine kinase - A new target for immune mediated inflammatory diseases?

Seminars in arthritis and rheumatism
2025

Zanubrutinib for the treatment of Bing-Neel syndrome.

British journal of haematology
2024

A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings.

Frontiers in immunology
2024

Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage.

Frontiers in immunology
2025

Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of Immunity.

International journal of neonatal screening
2024

Nutritional status in pediatric patients with predominant antibody deficiency.

Biomedica : revista del Instituto Nacional de Salud
2024

Infections, autoimmunity and immunodeficiencies are the leading etiologies of non-cystic fibrosis bronchiectasis in adults from the southwest of Colombia.

Biomedica : revista del Instituto Nacional de Salud
2025

Functional validation of a novel STAT3 'variant of unknown significance' identifies a new case of STAT3 GOF syndrome and reveals broad immune cell defects.

Clinical and experimental immunology
2025

Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans.

The Journal of experimental medicine
2025

Isolated loss of vaccine immunity in the protein losings syndrome in a patient with a reverse one and a half ventricle palliation ("failing Fontan-like physiology").

Cardiology in the young
2025

Differential regulatory effects of the N-terminal region in SYK-fusion kinases reveal unique activation-inducible nuclear translocation of ITK-SYK.

Scientific reports
2025

Sequelae of B-Cell Depleting Therapy: An Immunologist's Perspective.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
2025

A second look at secondary hypogammaglobulinemia.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
2024

Immunodeficiencies in Foals.

The Veterinary clinics of North America. Equine practice
2025

Persistent COVID-19 improved with immunoglobulin replacement therapy in Good's syndrome.

Respiratory investigation
2024

Nephrotic Syndrome and Recurrent Infection.

Iranian journal of allergy, asthma, and immunology
2025

Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with chronic lymphocytic leukemia (CLL) treated with Acalabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor: a case report.

Acta neurologica Belgica
2024

A novel mutation in FNIP1 associated with a syndromic immunodeficiency and cardiomyopathy.

Immunogenetics
2024

Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience.

World journal of pediatrics : WJP
2025

Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2024

Rare primary vasculitis: update on multiple complex diseases and the new kids on the block.

Advances in rheumatology (London, England)
2024

A single center experience on PI3K/AKT/MTOR signaling defects: Towards pathogenicity assessment for four novel defects.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2024

Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.

Journal of clinical immunology
2025

Pure Red Cell Aplasia in a Patient with Thymic Hyperplasia, Hypogammaglobulinemia and Adult T-cell Leukemia/Lymphoma.

Internal medicine (Tokyo, Japan)
2025

Clinical spectrum of and outcomes for Indian children with deficiency of adenosine deaminase 2 (DADA2): a multicentric study.

Rheumatology (Oxford, England)
2024

Good syndrome combined with multiple microbial pulmonary infections: case report and review of the literature.

Immunologic research
2024

Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments.

Advances in rheumatology (London, England)
2024

Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis.

Annals of hematology
2024

Deficiency of Adenosine Deaminase 2.

Turkish journal of haematology : official journal of Turkish Society of Haematology
2024

A Novel Variant of the PIK3R1 Gene Mutation Associated With SHORT Syndrome and Agammaglobulinemia.

Cureus
2024

Omenn Syndrome can Occur during Enzyme Therapy for Adenosine Deaminase Deficiency.

Journal of clinical immunology
2024

Transient hypogammaglobulinemia of infancy and unclassified syndromic immunodeficiencies are highly common in oesophageal atresia patients.

Scandinavian journal of immunology
2024

A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency.

Pediatric neurology
2024

Analysis of LRBA pathogenic variants and the association with functional protein domains and clinical presentation.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2024

Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.

Journal of medical virology
2024

Antibody Response Before and After the Booster Dose of Inactivated Corona Vaccine in Antibody Deficient Patients.

Iranian journal of allergy, asthma, and immunology
2024

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study.

European journal of neurology
2024

A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in Greece.

Medicina (Kaunas, Lithuania)
2024

Variable Syndromic Immunodeficiency in Patients with Biallelic PRIM1 Mutations.

Journal of clinical immunology
2024

Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies.

RMD open
2024

Case report: BTK inhibitors is effective in type II mixed cryoglobulinemia with wild-type MyD88.

Frontiers in immunology
2024

Clinical and Immunologic Features of a Patient With Homozygous FNIP1 Variant.

Journal of pediatric hematology/oncology
2024

Viral infections and inborn errors of immunity.

Current opinion in infectious diseases
2024

[COVID-19 in patients with Good syndrome: report of 4 cases and literature review].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2024

Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.

Frontiers in immunology
2024

Rituximab-induced hypogammaglobulinemia in nephrotic syndrome: what is the true burden?

Pediatric nephrology (Berlin, Germany)
2024

Hypogammaglobulinemia in 2 children with Zhu-Tokita-Takenouchi-Kim syndrome.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
2024

Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns.

Journal of clinical immunology
2024

Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen.

International journal of clinical pharmacology and therapeutics
2024

Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases.

Autoimmunity reviews
2024

CXCR4: from B-cell development to B cell-mediated diseases.

Life science alliance
2024

Safety and efficacy of biologic immunosuppressive treatment in juvenile idiopathic arthritis associated with inborn errors of immunity.

Frontiers in pediatrics
2024

CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies.

British journal of haematology
2024

[Incidence of hypogammaglobulinaemia in children with steroid-dependent/frequently relapsing nephrotic syndrome treated with rituximab and its association with severe infections].

Zhonghua yi xue za zhi
2024

Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacy.

Immunological reviews
2024

X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India.

International archives of allergy and immunology
2024

Good syndrome and cytomegalovirus retinitis: A literature review.

Survey of ophthalmology
2024

Unraveling the Natural History of Good's Syndrome: A Progressive Adult Combined Immunodeficiency.

The journal of allergy and clinical immunology. In practice
2023

In-depth blood immune profiling of Good syndrome patients.

Frontiers in immunology
2024

Immune compromise in patients with Down syndrome. A case series.

Archivos argentinos de pediatria
2023

Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24.

Cellular & molecular immunology
2024

Hypogammaglobulinemia and immune dysregulation-not just 2 sides of a coin.

The Journal of allergy and clinical immunology
2024

Cutaneous vasculitis in autoinflammatory diseases.

The Journal of dermatology
2023

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies.

Frontiers in immunology
2024

Biallelic Cys141Tyr variant of SEL1L is associated with neurodevelopmental disorders, agammaglobulinemia, and premature death.

The Journal of clinical investigation
2023

[Management of adverse effects in CAR T-cell therapy].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2023

Antibody Deficiency in Patients with Biallelic KARS1 Mutations.

Journal of clinical immunology
2023

A novel mutation in DNMT3B gene causing ICF1 syndrome in an infant with refractory thrombocytopenia.

Clinical immunology (Orlando, Fla.)
2023

Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet's disease and autoinflammation. A viewpoint.

Reumatismo
2023

Who's your data? Primary immune deficiency differential diagnosis prediction via machine learning and data mining of the USIDNET registry.

Clinical immunology (Orlando, Fla.)
2023

A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency.

Immunity, inflammation and disease
2024

Recurrent flare-associated urticaria in adenosine deaminase type 2 deficiency.

Rheumatology (Oxford, England)
2023

[Early detection of WHIM symdrome. A case report].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2023

A Narrative Review of the Neurological Manifestations of Human Adenosine Deaminase 2 Deficiency.

Journal of clinical immunology
2023

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.

Blood cancer journal
2023

Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study.

Immunity, inflammation and disease
2023

Inborn Errors of Immunity-the Sri Lankan Experience 2010-2022.

Journal of clinical immunology
2023

Kawasaki Disease and Inborn Errors of Immunity: Exploring the Link and Implications.

Diagnostics (Basel, Switzerland)
2023

Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review.

Frontiers in immunology
2023

Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma.

Clinical lymphoma, myeloma & leukemia
2023

Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports.

Journal of neuroendocrinology
2023

Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report.

Journal of clinical immunology
2023

[Good syndrome: a rare, unusual immunodeficiency condition].

Orvosi hetilap
2023

A novel variant in ALG1 gene associated with congenital disorder of glycosylation: A case report and short literature review.

Molecular genetics & genomic medicine
2023

Persistent and fatal severe acute respiratory syndrome coronavirus 2 infection in a patient with severe hypogammaglobulinemia: a case report.

Journal of medical case reports
2023

Impaired Response to Polysaccharide Vaccine in Selective IgE Deficiency.

Journal of clinical immunology
2023

Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving 20% Subcutaneous IgG Infusions at Home.

Journal of clinical immunology
2023

Severe CD8+ T Lymphopenia in WHIM Syndrome Caused by Selective Sequestration in Primary Immune Organs.

Journal of immunology (Baltimore, Md. : 1950)
2023

COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient.

iScience
2023

Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome.

Arthritis & rheumatology (Hoboken, N.J.)
2023

SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients.

Frontiers in immunology
2023

[Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia].

Revue medicale suisse
2023

Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey.

Pediatric nephrology (Berlin, Germany)
2023

Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency.

The Journal of allergy and clinical immunology
2023

Co-Occurring X-Linked Agammaglobulinemia and X-Linked Chronic Granulomatous Disease: Two Isolated Pathogenic Variants in One Patient.

Biomedicines
2023

Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study.

Rheumatology (Oxford, England)
2023

Haematopoietic Stem Cell Transplantation (HSCT) for Primary Immune System Disorders in Children: A Single Centre Experience.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2023

COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.

International journal of rheumatic diseases
2023

TNF-Blockade for Primary Stroke Prevention in Adenosine Deaminase 2 Deficiency: A Case Series.

Neurology(R) neuroimmunology & neuroinflammation
2023

Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma.

Transplantation and cellular therapy
2023

Bruton's tyrosine kinase inhibition attenuates disease progression by reducing renal immune cell invasion in mice with hemolytic-uremic syndrome.

Frontiers in immunology
2023

Serum Protein Electrophoretic in Children.

International journal of pediatrics
2023

Human genetic and immunological determinants of SARS-CoV-2 and Epstein-Barr virus diseases in childhood: Insightful contrasts.

Journal of internal medicine
2023

Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials.

Molecules (Basel, Switzerland)
2024

GOOD SYNDROME: CYTOMEGALOVIRUS RETINITIS CASE CHALLENGE.

Retinal cases & brief reports
2023

[Management of hypogammaglobulinemia].

La Revue de medecine interne
2023

Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome.

European journal of neurology
2022

National experience with adenosine deaminase deficiency related SCID in Polish children.

Frontiers in immunology
2023

The Importance of Endoscopy with Biopsy: Real-World Evidence of Gastrointestinal Involvement in Primary Immunodeficiency in Two Main Northern Italian Centres.

Biomedicines
2022

A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report.

Pediatric rheumatology online journal
2022

Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation.

European review for medical and pharmacological sciences
2022

SARS-COV-2 infections in inborn errors of immunity: A single center study.

Frontiers in immunology
2023

Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome.

Clinical journal of the American Society of Nephrology : CJASN
2022

[Common variable immune deficiency complicated by amyloidosis: a case report].

The Pan African medical journal
2022

Comparison of pulmonary lesions using lung ultrasound and high-resolution computed tomography in adult patients with primary humoral immunodeficiencies.

Frontiers in immunology
2023

Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae.

Clinical immunology (Orlando, Fla.)
2023

Ibrutinib: Pediatric First Approval.

Paediatric drugs
2022

COVID-19 in unvaccinated patients with inborn errors of immunity-polish experience.

Frontiers in immunology
2022

Immunogenicity and Safety of the Spikevax® (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency.

International archives of allergy and immunology
2022

Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency.

Frontiers in immunology
2022

Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.

Frontiers in immunology
2022

Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency.

Frontiers in immunology
2022

Real-world results with IgPro20 for hypo- or agammaglobulinemia in Japan.

Pediatrics international : official journal of the Japan Pediatric Society
2023

Break down the barriers of auto-inflammation: How to deal with a monogenic auto-inflammatory disease and immuno-haematological features in 2022?

Immunology
2023

Long-term prognosis of rituximab-induced hypogammaglobulinemia in children with complicated steroid-dependent nephrotic syndrome: impact of multiple rituximab courses.

Pediatric nephrology (Berlin, Germany)
2022

A Rare Autoinflammatory Disorder in a Pediatric Patient with Favorable Response to Etanercept: Sideroblastic Anemia with B Cell Immunodeficiency, Periodic Fevers, and Developmental Delay Syndrome.

Pediatric allergy, immunology, and pulmonology
2022

Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4WHIM variants.

Genes and immunity
2022

Various phenotypes of LRBA gene with compound heterozygous variation: A case series report of pediatric cytopenia patients.

International journal of immunopathology and pharmacology
2023

Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2022

Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome.

Aging
2022

Identification and analysis of deletion breakpoints in four Mohr-Tranebjærg syndrome (MTS) patients.

Scientific reports
2022

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.

Immunity
2022

Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.

Journal of clinical immunology
2022

Biallelic PAX5 mutations cause hypogammaglobulinemia, sensorimotor deficits, and autism spectrum disorder.

The Journal of experimental medicine
2022

Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

[Antibodydeficiencies Epidemiology, Clinical manifestation, Diagnostics and Therapy].

Therapeutische Umschau. Revue therapeutique
2022

Clinical and Hematologic Effects of Endotoxin in Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome Model Mice.

ImmunoHorizons
2022

Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity.

Frontiers in immunology
2022

Chronic Enteroviral Meningoencephalitis in a Patient with Good's Syndrome Treated with Pocapavir.

Journal of clinical immunology
2022

Algerian Registry for Inborn Errors of Immunity in Children: Report of 887 Children (1985-2021).

Journal of clinical immunology
2022

Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report.

Frontiers in immunology
2022

Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET).

Journal of clinical immunology
2023

The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)
2022

Hypogammaglobulinaemia and B cell lymphopaenia in Barth syndrome.

BMJ case reports
2022

Utility of targeted next generation sequencing for inborn errors of immunity at a tertiary care centre in North India.

Scientific reports
2023

T Cell Abnormalities in X-Linked Agammaglobulinaemia: an Updated Review.

Clinical reviews in allergy & immunology
2022

Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment.

Haematologica
2022

Long-term follow-up and future direction on the management of chronic lymphocytic leukemia/small lymphocytic leukemia.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
2022

Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.

Frontiers in immunology
2022

Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature.

Frontiers in immunology
2022

Decreased BAFF Receptor Expression and Unaltered B Cell Receptor Signaling in Circulating B Cells from Primary Sjögren's Syndrome Patients at Diagnosis.

International journal of molecular sciences
2022

Fatal SARS in X-Linked Lymphoproliferative Disease Type 1: A Case Report.

Frontiers in pediatrics
2022

Lipopolysaccharide Responsive Beige-like Anchor Protein Deficiency in a Patient with Autoimmune Lymphoproliferative Syndrome-like Disease Phenotype: A Case Report and Literature Review.

Iranian journal of allergy, asthma, and immunology
2022

A Sherlock Approach to a Kindred With a Variable Immunohematologic Phenotype.

The journal of allergy and clinical immunology. In practice
2022

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.

The Journal of allergy and clinical immunology
2022

Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report.

BMC infectious diseases
2023

Keratoconjunctivitis as a Single Entity in X-linked Agammaglobulinemia?

Ocular immunology and inflammation

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Agamaglobulinemia sindromática.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Agamaglobulinemia sindromática

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Rituximab-induced hypogammaglobulinemia in childhood nephrotic syndrome: a systematic review and meta-analysis.
    European journal of pediatrics· 2026· PMID 41843217mais citado
  2. A patient with WHIM syndrome presenting relatively low TREC, KREC, and housekeeping gene levels by newborn screening -a case report and the literature review.
    Immunological medicine· 2026· PMID 41793776mais citado
  3. Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity.
    Expert review of clinical immunology· 2026· PMID 41786511mais citado
  4. First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia.
    Frontiers in immunology· 2026· PMID 41727503mais citado
  5. Good's Syndrome Mirrors a Combined Immunodeficiency with Anti-Cytokine Antibodies in the Total Absence of B Cells.
    Journal of clinical immunology· 2026· PMID 41701387mais citado
  6. Prenatal detection of Gorlin-Goltz syndrome: a case report and focused review of the literature.
    Front Med (Lausanne)· 2026· PMID 41994461recente
  7. Epidemiological characteristics and co-occurrence patterns of Rothia species and respiratory pathogens: from population surveillance to mechanistic insights.
    J Oral Microbiol· 2026· PMID 41993048recente
  8. Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non-Syndromic Cases.
    Pediatr Blood Cancer· 2026· PMID 41992729recente
  9. Dual disorders: an overview.
    Ir J Psychol Med· 2026· PMID 41988798recente
  10. Co-produced evidence-based recommendations for cascade screening and secondary prevention in the relatives of people diagnosed with non-syndromic thoracic aortic disease.
    Front Cardiovasc Med· 2026· PMID 41987921recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:229720(Orphanet)
  2. MONDO:0016463(MONDO)
  3. GARD:20596(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q56013830(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Agamaglobulinemia sindromática
Compêndio · Raras BR

Agamaglobulinemia sindromática

ORPHA:229720 · MONDO:0016463
🇧🇷 Brasil SUS
Triagem
KREC (Kappa-deleting Recombination Excision Circles)
PNTN
Fase 4
Incidência BR
1:200.000
Geral
Medicamentos
3 registrados
MedGen
UMLS
C0086438
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades